Skip to main content

Menold Daniel's Form 4 filing

CymaBay Therapeutics, Inc. (CBAY) · filed Dec 15, 2023

Accession no.
0001062993-23-022638
Filed
Dec 15, 2023
Trade date
Dec 15, 2023
Filing delay
Same day
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $472.6K. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Menold DanielCIK 0001705745Officer (Vice President, Finance)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 15, 2023Common StockMOption exerciseAcquired+10,000$4.05+$40,50010,000Direct
Dec 15, 2023Common StockSSaleDisposed−10,000$21.98−$219,8000Direct
Dec 15, 2023Common StockMOption exerciseAcquired+11,497$8.43+$96,919.7111,497Direct
Dec 15, 2023Common StockSSaleDisposed−11,497$21.99−$252,819.030Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 15, 2023Common StockMOption exerciseDisposed−10,000$0.00$0145,109Direct
Dec 15, 2023Common StockMOption exerciseDisposed−11,497$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)